Compounds of formula (I), and salts and pro-drugs thereof: Formula (I) wherein for example R
1
is optionally substituted aryl or heteroaryl; Y is a linking group selected from, for example, a direct bond, and a (substituted) alkyl chain; R
2
is an optionally substituted aryl, an optionally substituted cycloalkyl or an optionally substituted heterocyclic group; are described. Processes to make such compounds and their use as DGAT inhibitors, for example in the treatment of obesity, are also described.
式(I)的化合物,以及其盐和前药:其中,例如R1是可选取代芳基或杂环芳基;Y是选择自直接键和(取代)烷基链等的连接基;R2是可选取代芳基、可选取代环烷基或可选取代杂环基团。还描述了制备此类化合物的方法及其作为DGAT
抑制剂的用途,例如在肥胖症的治疗中。